SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to the upcoming April 20th inclusion in the Nasdaq-100 Index, which has triggered a surge of institutional buying and massive interest from retail traders. The community is sharply divided between bulls chasing the parabolic AI-driven demand and bears warning of a potential bubble similar to past semiconductor sell-offs.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors speculate on potential early FDA approval for Deramiocel and the expected appointment of a new CBER director. The community is actively discussing rumors regarding the hiring of a former company VP to a high-level FDA role and remains bullish on the company's long-term prospects despite recent price volatility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending as investors debate whether the stock is a deep-value opportunity or a long-term value trap, fueled by rumors of potential M&A activity and calls for stronger leadership from the new CEO. The community is actively discussing the company's aggressive share buybacks, recent partnerships with major social platforms, and persistent frustration over the stock's stagnant price performance despite strong free cash flow.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing extreme volatility and parabolic price action driven by an intense short squeeze, as retail traders draw parallels to previous high-profile squeeze events. While bullish sentiment is fueled by the stock's massive momentum and high short interest, skeptical investors and short sellers are warning of a potential blow-off top, pointing to weak fundamentals and the possibility of management diluting shares via an at-the-market program.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is seeing strong momentum as the community focuses on its pivot to high-performance computing, with investors actively discussing potential contract announcements and its ability to secure premium power for AI infrastructure. Traders are closely monitoring a major breakout as technical indicators and institutional interest suggest the stock is gaining relative strength despite broader market volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor scrutiny as shares endure a prolonged period of downward volatility, despite the company highlighting new AI-driven utility and supply chain platform announcements. The community is actively debating whether the stock's recent performance represents an attractive entry point for a long-term AI infrastructure play or if mounting debt and competitive pressures from new AI entrants will continue to weigh on the share price.

Maulcoin

Maulcoin is trending as a high-conviction community movement driven by a dedicated, Star Wars-themed 'Mauler' fanbase that is actively coordinating to push the project toward its next major market cap milestones. Investors are heavily focused on organic growth, viral social engagement, and a 'hold-at-all-costs' strategy, specifically rallying around the anticipation of official chart listings and potential expansion heading into May.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a massive rally and high trading volume driven by multiple strategic partnerships, including major infrastructure deals with Google and Elon Musk's Terafab project. While the stock has reached multi-year highs and captured significant investor momentum, community discussion remains polarized between bullish long-term sentiment regarding Intel's turnaround and bearish concerns about its premium valuation and overextended technical indicators.

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.

ImageneBio Inc.

ImageneBio, Inc.

ImageneBio is generating significant investor attention as community members debate its long-term potential in the dermatology and hair-loss sectors following a recent private placement. While some traders are focused on short-term price action and potential momentum plays, others are actively analyzing the company's clinical trial updates and institutional holdings to gauge its valuation relative to its cash reserves.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus (PMV) is trending as its community leans into a high-conviction, "infection-themed" meme culture, actively promoting the token across social platforms. Supporters are highlighting the project's long-term organic growth and recent collaborative efforts with other established meme coin communities, signaling strong belief in the brand's resilience through volatile market conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analysts Offer Predictions for Adagene FY2026 Earnings

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Free Report) - Equities research analysts at HC Wainwright issued their FY2026 earnings estimates for Adagene in a research report issued on Tuesday, April 7th. HC Wainwright analyst A. He forecasts that the company will post earnings of ($0.37) per share fo...

Guggenheim Issues Positive Forecast for Adagene (NASDAQ:ADAG) Stock Price

Guggenheim raised their price target on Adagene from $9.00 to $10.00 and gave the stock a "buy" rating in a research report on Monday...

<ul class="summary-bullets"><li>Adagene also announced an update from the Phase 1b/2 study of Muzastotug in combination with Keytruda in patients with Microsatellite Stable Colorectal Cancer with no liver metastases.</li><li>The company stated that the results show an improved durability of response among patients in the trials.</li><li>Adagene added that Muzastotug, in combination with Merck’s Keytruda, has received Fast Track designation from the FDA.</li></ul>Adagene Inc. (ADAG) shares tanked nearly 10% in Thursday’s opening trade after the company announced a slew of updates, including the pricing of a $70 million public offering of its American depository shares.Adagene priced the public offering at $3.75 per ADS, representing a discount of nearly 19% from ADAG’s closing price on Wednesday. The offering is expected to close on April 6, 2026.Adagene also announced an update from the Phase 1b/2 study of Muzastotug in Combination with Keytruda in patients with Microsatellite Stable Colorectal Cancer (MSS CRC) with no liver metastases. The company stated that the results show an improved durability of response among patients in the trials.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/ADAG">Adagene</a> trended in the ‘bearish’ territory at the time of writing.<h2 class="st-heading-2">Adagene Provides Update On Muzastotug Trials</h2>The company stated that Muzastotug, in combination with Merck’s Keytruda, achieved an overall response rate (ORR) of 31% in the combined 20 mg/kg dose cohort, compared to an ORR of 13% in the 10 mg/kg dose cohort.Adagene added that the median duration of response (mDOR) has not yet been achieved in the 20 mg/kg dose cohort, with responses ongoing beyond 9 months. However, the 10 mg/kg dose cohort achieved an mDOR of 6.2 months.The Progression-Free Survival (PFS) stood at 6.7 months in the 20 mg/kg cohort, outlasting the 4.8 months observed in the 10 mg/kg dose cohort, according to the company.Adagene stated that Muzastotug, in combination with Merck’s Keytruda, has received Fast Track designation from the U.S. Food and Drug Administration (FDA).In the 10 mg/kg cohort, the median overall survival was 19.8 months, with 48% of patients alive at two years. In the 20 mg/kg cohort, one-year survival was 80.8%, compared with 70.1% in the 10 mg/kg cohort.The company added that there was a 4% discontinuation rate across the two doses, and that there were no dose-limiting toxicities observed.<h2 class="st-heading-2">Adagene Teams Up With Incyte</h2>Adagene stated that it has partnered with Incyte Corp. (INCY) to evaluate the combination of muzastotug and INCA33890 in patients with MSS CRC with or without liver metastases.The company added that as a monotherapy, INCA33890 has demonstrated promising clinical efficacy and safety in immune checkpoint sensitive and insensitive cancers, including MSS CRC with and without liver metastases.<a href="https://stocktwits.com/symbol/ADAG">ADAG stock</a> is up 130% year-to-date. The Invesco Golden Dragon China ETF (PGJ) is down 14% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-china-made-ev-sales-march-2026/cZ7xoOYRI8R">Tesla’s China-Made EV Sales Rise 9% In March, Registering Fifth Straight Month Of Gains: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trading digital board showing the data on global stock market crash. | Image source: Getty Images

Why Is ADAG Stock Tanking Today?

Adagene priced the public offering of its American depository shares at $3.75 per ADS, representing a discount of nearly 19% from ADAG’s closing price on Wednesday.

Equity

Adagene (NASDAQ:ADAG) Announces Earnings Results, Beats Expectations By $0.24 EPS

Adagene (NASDAQ:ADAG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28...

Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Expands By 44.6%

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 74,016...

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Buy" by Analysts

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has been assigned a consensus rating of "Buy" from the five analysts that are currently covering the company, Marketbeat reports. One...

Adagene (NASDAQ:ADAG) Raised to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Adagene to a "hold" rating in a research report on Saturday...

Adagene (ADAG) to Release Earnings on Monday

Adagene (NASDAQ:ADAG) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...

Adagene Spotlights ADG126 at Leerink, Teases New MSS Colorectal Cancer Data Update Soon

Adagene (NASDAQ:ADAG) outlined its clinical and strategic priorities at Leerink Partners' global healthcare conference, with Chief Strategy Officer Mickael Chane-Du focusing primarily on the...

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Short Interest Down 24.5% in February

Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) saw a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 47,428 shares, a...

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Adagene Inc - ADR

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

Current Price	$3.90
Prev Close	$3.80
Open	$3.87
Dividend Yield	0.00%
50-Day Moving Average	$3.41
Beta	0.07
Avg. Volume	237,415.95
PE Ratio	-10.15

52-Week High	$4.75
52-Week Low	$1.30
Market Capitalization	$180.07M
EPS (Annual)	-$0.374
Price to Book	5.09
Revenue Per Employee	$60,087.42

ADAG
Adagene Inc - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest ADAG News

ADAGAdagene Inc - ADR